Beta-3 Adrenergic Receptor Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Beta-3 Adrenergic Receptor Neurons</th> </tr> <tr> <td class="label">Category </td> <td>Adrenergic Receptor Neurons</td> </tr> <tr> <td class="label">Location </td> <td>Hypothalamus, Brainstem, Limbic System</td> </tr> <tr> <td class="label">Receptor Type </td> <td>β3-AR (ADRB3)</td> </tr> <tr> <td class="label">Signaling </td> <td>Gs-coupled, excitatory</td> </tr> <tr> <td class="label">Gene </td> <td>ADRB3 (chromosome 8p12)</td> </tr> <tr> <td class="label">Protein </td> <td>Beta-3 adrenergic receptor</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td> </tr> <tr> <td class="label">Database</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253
...
Beta-3 Adrenergic Receptor Neurons
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Beta-3 Adrenergic Receptor Neurons</th> </tr> <tr> <td class="label">Category </td> <td>Adrenergic Receptor Neurons</td> </tr> <tr> <td class="label">Location </td> <td>Hypothalamus, Brainstem, Limbic System</td> </tr> <tr> <td class="label">Receptor Type </td> <td>β3-AR (ADRB3)</td> </tr> <tr> <td class="label">Signaling </td> <td>Gs-coupled, excitatory</td> </tr> <tr> <td class="label">Gene </td> <td>ADRB3 (chromosome 8p12)</td> </tr> <tr> <td class="label">Protein </td> <td>Beta-3 adrenergic receptor</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology (CL)</td> <td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td> </tr> <tr> <td class="label">Database</td> <td>ID</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000109](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td> </tr> <tr> <td class="label">Cell Ontology</td> <td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td> </tr> </table>
Beta 3 Adrenergic Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Beta-3 adrenergic receptors (β3-AR, encoded by ADRB3) are Gs-coupled receptors with distinct pharmacological properties and distribution patterns in the central nervous system. While historically considered primarily a peripheral metabolic regulator, emerging research reveals important CNS functions including thermoregulation, energy homeostasis, stress response, mood regulation, and potential neuroprotective effects in neurodegenerative diseases. [@jain2019]
Overview
Mermaid diagram (expand to render)
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
Morphology : adrenergic neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000109)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)
[OBO Foundry (CL:0000109)](http://purl.obolibrary.org/obo/CL_0000109)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
[Cell Ontology (CL:0000109)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000109)
[OBO Foundry (CL:0000109)](http://purl.obolibrary.org/obo/CL_0000109)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Molecular Properties
Receptor Structure The β3-adrenergic receptor is a 7-transmembrane domain GPCR with distinct structural features that confer resistance to desensitization compared to β1- and β2-ARs. It exhibits unique pharmacological properties including sensitivity to selective agonists such as mirabegron.
Family : β-adrenergic receptors (β1, β2, β3)
G protein : Gs (primary), Gi (secondary in some contexts)
Second messenger : cAMP increases (Gs pathway)
Distribution : More limited in CNS compared to β1/β2
Structure : Class A GPCR with distinct ligand binding pocket
Signaling Pathways
cAMP/PKA pathway : Primary signaling mechanism through Gs protein activation of adenylyl cyclase
p38 MAPK pathway : Stress-activated signaling, particularly in adipocytes
ERK1/2 pathway : Involved in metabolic and proliferative responses
β-arrestin pathways : β3-AR shows biased signaling with less β-arrestin recruitment than β1/β2
Distribution in the Brain While β3-AR expression in the brain is more limited than β1/β2, specific populations express functional β3-AR:
Hypothalamus :
Arcuate nucleus: Energy homeostasis regulation
Paraventricular nucleus: Stress response and autonomic control
Preoptic area: Thermoregulation
Brainstem :
Nucleus of the solitary tract (NTS): Cardiovascular and visceral integration
Dorsal raphe nucleus: Mood regulation interactions
Limbic system :
Amygdala: Emotional processing
Hippocampus: Limited expression, potential memory effects
Brown adipose tissue : Profuse peripheral innervation for thermogenesis
Physiological Functions
β3-AR in the hypothalamus and brown adipose tissue (BAT) play central roles in energy homeostasis:
Thermogenesis : BAT thermogenesis is primarily mediated through β3-AR activation, uncoupling protein 1 (UCP1) expression, and heat generation
Energy expenditure : Increased metabolic rate through fatty acid oxidation
Food intake : Hypothalamic β3-AR signaling modulates appetite and satiety pathways
Body weight : β3-AR agonist administration reduces adiposity in experimental models
Stress Response
HPA axis modulation : β3-AR in the PVN and amygdala modulate hypothalamic-pituitary-adrenal (HPA) axis activity
Anxiety-related behaviors : Conflicting evidence suggests both anxiogenic and anxiolytic effects depending on brain region and context
Stress-induced metabolism : β3-AR mediates catecholamine-induced metabolic responses to stress
Mood and Reward
Depression : β3-AR expression is altered in depression; some studies show reduced β3-AR in prefrontal cortex of depressed patients
Antidepressant effects : β3-AR agonists show antidepressant-like effects in animal models
Reward circuitry : Limited evidence suggests β3-AR in nucleus accumbens may modulate dopamine-mediated reward
Disease Involvement
Alzheimer's Disease
Metabolic dysfunction : β3-AR dysregulation may contribute to cerebral metabolic deficits in AD
Amyloid pathology : Some evidence suggests β3-AR activation may affect amyloid precursor protein processing
Neuroinflammation : β3-AR on glial cells may modulate neuroinflammatory responses
Therapeutic potential : β3-agonists being investigated for metabolic aspects of AD [1](https://doi.org/10.1016/j.neurobiolaging.2020.03.015)
Parkinson's Disease
Motor complications : β3-AR in the striatum may modulate levodopa-induced dyskinesias
Autonomic dysfunction : β3-AR dysregulation contributes to orthostatic hypotension and other autonomic symptoms in PD
Metabolic changes : Altered energy metabolism in PD may involve β3-AR pathways [2](https://doi.org/10.1016/j.parkreldis.2019.05.025)
Obesity : β3-agonists (mirabegron) promote weight loss through thermogenesis
Type 2 diabetes : β3-AR agonists improve insulin sensitivity
Non-alcoholic fatty liver disease : Potential therapeutic target
Depression and Anxiety
Major depressive disorder : Altered β3-AR expression in limbic regions
Anxiety disorders : Region-specific effects on anxiety-like behaviors
Seasonal affective disorder : Possible role in light-induced mood effects through thermoregulation
Therapeutic Implications
Approved β3-AR Agonists
Mirabegron : FDA-approved for overactive bladder; also promotes brown adipose tissue thermogenesis
Vibegron : Another approved β3-agonist for overactive bladder
Solabegron : Investigational agent with improved CNS penetration
Investigational Therapies
CNS-penetrant β3-agonists : Under development for depression and metabolic disorders
β3/β1 dual agonists : Combining thermogenic and cardiac effects
Allosteric modulators : Positive allosteric modulators for enhanced selectivity
Clinical Considerations
Cardiovascular safety : β3-agonists can increase blood pressure and heart rate
Metabolic effects : Must monitor for improvements in metabolic parameters
Combination potential : May combine with GLP-1 agonists or other metabolic agents
Research Directions
Brain-penetrant agents : Developing β3-agonists that cross the blood-brain barrier
PET ligands : Imaging β3-AR in living brain
Genetic studies : β3-AR polymorphisms and disease associations
Combination therapies : β3-agonists with other neuropsychiatric agents
Adrenergic Neurotransmission
Adrenergic Receptors
Beta-1 Adrenergic Receptor Neurons
Beta-2 Adrenergic Receptor Neurons
Hypothalamic Neurons
Brown Adipose Tissue
External Links
[Wikipedia: Adrenergic receptor](https://en.wikipedia.org/wiki/Adrenergic_receptor)
[IUPHAR/BPS Guide to Pharmacology: β3-adrenoceptor](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=269)
[UniProt: ADRB3](https://www.uniprot.org/uniprot/P13945)
Background The study of Beta 3 Adrenergic Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Pathway Diagram The following diagram shows the key molecular relationships involving Beta-3 Adrenergic Receptor Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description